4basebio H1 2026 loss widens to £8.9 million; revenue drops 74.9% to £0.3 million
Bitget2026/09/28 06:06- 4basebio posted a loss for the six months ended June 30, 2026 of GBP 8.9 million, widening from GBP 7.8 million.
- Revenue fell 74.9% to GBP 262,000, while sales orders climbed 210% to GBP 1.2 million.
- Operating loss widened to GBP 8.9 million from GBP 8.3 million, and basic loss per share deepened to GBP 0.57 from GBP 0.50.
- Cash and cash equivalents slid to GBP 14.1 million from GBP 17.8 million following a EUR 7 million drawdown under the 2Invest AG loan facility.
- Chief executive Amy Walker cited strong commercial momentum, with a qualified pipeline of GBP 63 million, up six-fold since Q3 2025.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation
The Federal Reserve Eyes $1.8 Trillion in “Shadow Credit”: Dallas and New York Fed Launch First Private Credit Survey
The Dallas and New York Federal Reserves have launched an investigation into private credit lending standards, covering an industry worth 1.8 trillions USD, with a minimum threshold of 50 millions USD. The results will be released in the first quarter of 2027.
Tom Lee Says a VIX Signal Points to a Stock Market Bottom
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.
Crypto prices
More
